Gregory Verdine, a founder or co-founder of several publicly-listed pharmaceutical companies, has joined WuXi PharmaTech's investment arm as a venture partner.
Harvard professor and serial entrepreneur Gregory Verdine has taken a venture partner position at WuXi Healthcare Ventures, the corporate venturing arm of China-based pharmaceutical company WuXi PharmaTech.
Verdine, a Harvard Medical School Professor, has developed a new kind of therapeutics called stapled peptides. They are undergoing clinical development and are being advanced to treat conditions thought to be ‘undruggable’.
In addition to his academic work, Verdine has been a founder or co-founder of biotechnology companies including: Enanta Pharmaceuticals,
